Myasthenia gravis.
Artículo
en Inglés
| IMSEAR
| ID: sea-85371
ABSTRACT
Myasthenia gravis is the prototype neuromuscular disease with immunological pathogenesis. The recognition and interpretation of the symptoms should be stressed as the diagnosis is initially achieved on clinical ground. Tests in the areas of immunology, electrophysiology and imaging further help the diagnosis, management and prognosis of the condition. The recent knowledge of immunology seems to point to variations in the immune abnormalities, but it remains to be seen whether the differences have clinical relevance. With the availability of intensive care units, the management of acute events in the myasthenic patients has improved considerably and the morbidity is reduced. Long term remissions are achievable in majority of patients, with supervised use of immunosuppression. In the modern times, the grave connotations of the name myasthenia gravis may be only rarely justified.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Humanos
/
Inhibidores de la Colinesterasa
/
Receptores Colinérgicos
/
Electromiografía
/
Anticuerpos
/
Miastenia Gravis
Tipo de estudio:
Estudio pronóstico
Idioma:
Inglés
Año:
2004
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS